Vext Science, Inc. Doubles Cannabis Dispensary Presence in Arizona and Commences Production in Oklahoma

Shares :

5
(2)
Vext Science, Inc. (CNW Group/Vext Science, Inc.)

Management Provides General Business Update

VANCOUVER, April 8, 2020 /CNW/ – Vext Science, Inc. (“VEXT” or the “Company“) (OTCQX: VEXTF; CSE: VEXT) today announced the closing of an acquisition in the State of Arizona, the commencement of production in its joint venture in Oklahoma and provides a general reporting update.

Acquisition of 100% of RDF Management Company, LLC and Intellectual Property

Effective on April 6, 2020, VEXT closed the acquisition of an Arizona based company to provide exclusive turn-key services for the management, administration and operation of Organica Patient Group, Inc. (“Organica”), an Arizona not for profit corporation, which was issued and holds in good standing, a Medical Marijuana Dispensary Registration Certificate, by the Arizona Department of Health Services in the State of Arizona (collectively the “Transaction“).  Such services includes but is not limited to the management, administration and operation of its medical marijuana dispensary, cultivation, extraction, kitchen and infusion operations.

Organica has been operational in the Arizona market since 2013, with its retail dispensary located and operational in Chino Valley, Arizona and its offsite cultivation facility located in and operational in Prescott Valley, Arizona. Organica cultivates and produces medical marijuana and medical marijuana product which is sold and distributed on a retail and wholesale basis in State of Arizona.

Consideration for the Transaction, included the following:

  1. Issuance of 67,000 Class A common shares of VEXT (the “Multiple Voting Shares“), each Multiple Voting Share carrying one hundred votes and subject to the appropriate terms and restrictions.  Such Multiple Voting Shares: (i) do not trade on the Canadian Securities Exchange (the “CSE“), (ii) are subject to a Canadian hold period of four months and a day from the date of issuance, (iii) are subject to a US securities law legend and (iv) are subject to a coattail agreement designed to prevent transactions that otherwise would deprive holders of the Company’s subordinate Common Shares (which trade on the CSE) of rights applicable to take-over bid legislation to which they would have been entitled to if the Multiple Voting Shares had been Common Shares; and 
  2. Issuance of a promissory note by VEXT in the aggregate sum of USD$5.5mm and along with other standard closing adjustments. 

Commencement of Operations in Oklahoma

Additionally, the Company announced that its joint venture in Oklahoma has commenced production operations and is producing cannabis products for sale and distribution to the Oklahoma cannabis market as of the date of this news release.  The Company’s joint venture with Texoma Processing and Extraction, LLC, an Oklahoma limited liability company, located in Madill, Oklahoma (“Texoma“) has received a Certificate of Operation from the state of Oklahoma and includes a licensed cannabis processing, extraction and production operation (collectively the “Processing Facility“), in addition to a licensed outdoor cannabis cultivation facility. The new, state-of-the-art Processing Facility is expected to commence operations, including the production of VEXT’s Vapen branded cannabis concentrates, edibles and extraction products, to be distributed to dispensaries in the State of Oklahoma in late April 2020.

The Company also entered into a nonbinding Letter of Intent with Appalachian Pharms Processing LLC (“Appalachian Pharms“), an Ohio limited liability company, located in Jackson, Ohio.  Appalachian Pharms’ operations will commence in April, and subject to execution of additional contractual agreements and the approval of the Ohio Department of Commerce, the Vapen brand of products will be produced and distributed to the Ohio cannabis market.  

Eric Offenberger, Chief Executive Officer of VEXT commented:

“We are executing on our expansion strategy on multiple fronts. First, we have successfully expanded our presence in Arizona, our home market and the third largest medical only cannabis market in the U.S. With the closing of the Arizona Transaction and the associated rights to provide services to Organica’s vertically integrated cannabis operations, we have increased our presence in this fast-growing market and improving our access to quality source materials. Second, we have also expanded our presence in two new high-growth markets, Oklahoma and Ohio (subject to regulatory approval). As such, we are on track to  have production and or sales of Vapen Branded Product in five (5) additional states, three (3) of which are joint ventures, with the goal of having seven (7) total joint venture and/or investment partnerships closed and operational by the end of calendar year 2020.” 

As both medical and economic concerns have increased over the past two weeks, regarding the spreading and impact of the novel coronavirus known as “COVID-19”, the Company wants to assure its shareholders that it is taking all the necessary steps to protect employees and customers, ensuring full compliance with established guidelines.  The safety of our employees and customers have been a primary focus.   

About Vext Science, Inc.

Vext Science, Inc. is a US-based Cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen™ Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. Based in Arizona, Vext Science, Inc. has one of the leading THC concentrates, edibles, and distillate cartridge brands sold in most of the state’s 100+ dispensaries. Herbal Wellness Center is one of Arizona’s leading dispensaries and we execute all aspects of the cultivation, extraction, edibles infusion and manufacturing processes which insures a product of the highest quality and purity. Product quality and purity are core to our marketing strategy. Vext Science, Inc. is executing its business growth by leveraging experience and expertise in extractions, product manufacturing, and marketing to expand in the U.S. and internationally through revenue and profit-sharing joint venture partnerships. For more information visit our website at www.VextScience.com.


ALERT : Revive Therapeutics (RVV) Announces Filing of FDA Pre-IND Meeting| HERE


If you like this article sign up below for our free newsletter

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.


Click on a star to rate this article !

Average rating 5 / 5. Vote count: 2

No votes so far! Be the first to rate this post.


Shares :